Table 1.
Level of abnormal maturation (WHO 2005) | WHO 2005 classification [61] | SIN classification [60] | Ljubljana classification [59] | Amended Ljubljana classification [58] | WHO 2017 [8] |
---|---|---|---|---|---|
Squamous hyperplasia | Squamous hyperplasia | Squamous hyperplasia | Low-grade SIL | Low-grade dysplasia | |
Lower 1/3 | Mild dysplasia | SIN 1 | Basal/parabasal hyperplasia | ||
1/3 to 1/2 |
Moderate Dysplasia |
SIN 1 or 2 | Atypical hyperplasia | High-grade SIL | |
Upper 1/2–3/4 | SIN 2 | High-grade dysplasia* | |||
Full thickness | Severe dysplasia | ||||
Carcinoma in situ | Carcinoma in situ | Carcinoma in situ |
*A grade of carcinoma in situ may be used if a three-tiered system is preferred
SIN squamous intraepithelial neoplasia, SIL intraepithelial lesion